Gladstone Institutional Advisory’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History
Bought
Maintained
Sold
Other funds holding GNOM
Gladstone Institutional Advisory's GNOM Position: Q3 2026 in Review
Gladstone Institutional Advisory increased its Global X Genomics & Biotechnology ETF (GNOM) stake by 27% in Q3 2026, buying an estimated $133K and bringing the position to 10,284 shares worth $725K. The position accounts for 0.02% of the portfolio, ranked #548.
Gladstone Institutional Advisory first reported a position in GNOM in Q2 2026 and has held it in 2 quarters since. 51 funds tracked by Wall St. Rank hold GNOM as of Q3 2026.
- Gladstone Institutional Advisory held 10,284 shares of Global X Genomics & Biotechnology ETF worth $725K as of Q3 2026.
- Gladstone Institutional Advisory bought 2,182 Global X Genomics & Biotechnology ETF shares in Q3 2026, an estimated $133K.
- Global X Genomics & Biotechnology ETF made up 0.02% of Gladstone Institutional Advisory's portfolio in Q3 2026, its #548 holding.
- Gladstone Institutional Advisory first reported a position in Global X Genomics & Biotechnology ETF in Q2 2026 and has held it in 2 quarters since.
- 51 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q3 2026.
Based on Gladstone Institutional Advisory's 13F filing for Q3 2026, filed 13 Nov 2026.